LOBLAW COS LTD/ CA5394811015 /
04.06.2024 10:01:52 | Изменение 0.00 | Объем сделки | Бид10:01:52 | Предложение10:01:52 | Рыночная капитализация | Дивидендная доходность | Коэффициент Цена/Доход |
---|---|---|---|---|---|---|---|
106.00EUR | 0.00% | - Оборот: - |
106.00Величина цены спроса: - | 108.00Величина цены предложения: - | 34.02 млрдEUR | - | - |
GlobeNewswire
10:00
HashiCorp brings The Infrastructure Cloud to Europe and expands Infrastructure and Security Lifecycl...
GlobeNewswire
10:00
FSLY INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Fastly, Inc. Investors with Su...
GlobeNewswire
10:00
PERI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Perion Network Ltd. Investors ...
GlobeNewswire
10:00
AXTI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that AXT Inc Investors with Substan...
GlobeNewswire
10:00
HRBR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Harbor Diversified, Inc. Inves...
GlobeNewswire
10:00
VSTS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Vestis Corporation Investors w...
GlobeNewswire
10:00
ALT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Altimmune, Inc. Investors with ...
GlobeNewswire
10:00
IG Group Has Fully Integrated the Relay42 Customer Data Platform to Power Customer Acquisition and P...
GlobeNewswire
9:30
NewHydrogen CEO Steve Hill Discusses Challenges of Translating Cutting-edge Science into Marketable ...
GlobeNewswire
9:00
NXP and ZF Collaborate on SiC-Based Traction Inverters to Boost Electric Vehicle Powertrains
GlobeNewswire
9:00
World of Dypians Wins the BNB Chain DAU Incentive Program, Securing $60,000 in BNB
GlobeNewswire
9:00
ExeVir Bio Announces Exceptional Virus Neutralization Potency of its Variant-proof XVR013m Antibody ...
- Первая страница
- Назад
- 1
- 2
- 3
- 4
- Следующий
- Последняя страница